With Five-Year Ban On Fetal Tissue Studies Lifted, Scientists Are Striving To Make Up For Lost Time

With Five-Year Ban On Fetal Tissue Studies Lifted, Scientists Are Striving To Make Up For Lost Time Author: MYRNA E. WATANABE, pp.1 delayed by the moratorium, that may relieve human suffering Sometime this month, the National Institutes of Health will announce the recipients of the first federal grants since 1988 for research on human fetal tissue transplants using material derived from elective abortions--the main source of live and healthy fetal tissue that can be maintained in culture

| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Author: MYRNA E. WATANABE, pp.1

Sometime this month, the National Institutes of Health will announce the recipients of the first federal grants since 1988 for research on human fetal tissue transplants using material derived from elective abortions--the main source of live and healthy fetal tissue that can be maintained in culture and used for therapeutic transplants.

Proposals for the projects were submitted in early 1993, only a few days after newly inaugurated President Bill Clinton lifted a five-year- old moratorium on federal funding for such research. Throughout the ban's duration, it was vociferously challenged by scientists who regarded it as a serious roadblock in the pursuit of cures for many human diseases; the ire of these scientists was heightened by the widespread assumption that the moratorium resulted from pressure applied on the White House by anti- abortion groups.

The moratorium prevailed until this year, however, despite the recommendations by a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Myrna Watanabe

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo